U.S. Department of Health and Human Services
Clinical Trials Search Results
Search results 1 - 10 of 11 for FDA-Approved Opportunistic Infection and Coinfection Drugs, Valganciclovir Hydrochloride
Valganciclovir to Reduce T Cell Activation in HIV Infection
Condition: HIV Infections; Cytomegalovirus Infections
NCT ID: NCT00264290- Red stop iconCompleted
- Text file iconHas Results
- Email this trial
Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV
Condition: Cytomegalovirus Infections; HIV Infections
NCT ID: NCT00006145- Red stop iconCompleted
- Globe iconEn español
- Email this trial
Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection
Condition: Cytomegalovirus Retinitis; HIV Infections
NCT ID: NCT00017784- Question Mark iconUnknown status
- Email this trial
A Study of Valganciclovir in the Treatment of Cytomegalovirus (CMV) Retinitis in Patients With AIDS
Condition: Cytomegalovirus Retinitis; HIV Infections
NCT ID: NCT00002222- Red stop iconCompleted
- Email this trial
Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia
Condition: Pneumonia; HIV/AIDS; Tuberculosis; Cytomegalovirus Infections
NCT ID: NCT03915366- Green tick iconNot yet recruiting
- Email this trial
Valganciclovir Four Weeks Prior to cART Initiation Compared to Standard Therapy for Disseminated Kaposi Sarcoma
Condition: Kaposi Sarcoma; Human Immunodeficiency Virus; Immune Reconstitution Syndrome
NCT ID: NCT03296553- Red stop iconActive, not recruiting
- Email this trial
A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes
Condition: Cytomegalovirus Retinitis; HIV Infections
NCT ID: NCT00002377- Red stop iconCompleted
- Email this trial
Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity
Condition: Lymphoproliferative Disorder; HHV-8; Malignancy; HIV
NCT ID: NCT00092222- Green tick iconRecruiting
- Email this trial
Dose Escalation & Expansion Study of Oral VRx-3996 & Valganciclovir in Subjects With EBV-Associated Lymphoid Malignancies
Condition: Epstein-Barr Virus Associated Lymphoma; Lymphoproliferative Disorders
NCT ID: NCT03397706- Green tick iconRecruiting
- Email this trial
Tocilizumab for KSHV-Associated Multicentric Castleman Disease
Condition: Castleman Disease; Castleman's Disease; Giant Lymph Node Hyperplasia
NCT ID: NCT01441063- Red stop iconActive, not recruiting
- Email this trial
Email Updates
